[1]黄海霞*,何克静,蔡琳,等.艾滋病阳性孕妇应用三联抗病毒药物治疗的妊娠结局研究[J].中国计划生育和妇产科,2018,(12):64-66,72.
 HUANG Hai-xia*,HE Ke-jing,CAI Lin,et al.A retrospective study of pregnancy outcomes of HIV infected women treated by three combined high efficient antiretroviral drugs[J].Chinese Journal of Family Planning & Gynecotokology,2018,(12):64-66,72.
点击复制

艾滋病阳性孕妇应用三联抗病毒药物治疗的妊娠结局研究
分享到:

《中国计划生育和妇产科》[ISSN:1674-4020/CN:51-1708/R]

卷:
期数:
2018年12期
页码:
64-66,72
栏目:
论著与临床
出版日期:
2018-12-25

文章信息/Info

Title:
A retrospective study of pregnancy outcomes of HIV infected women treated by three combined high efficient antiretroviral drugs
作者:
黄海霞1*何克静2蔡琳2祝昭惠2赵萍2
1.400000重庆,重庆市公共卫生医疗救治中心妇产科;2. 610066四川成都,成都市公共卫生临床医疗中心
Author(s):
HUANG Hai-xia1* HE Ke-jing2 CAI Lin2 ZHU Zhao-hui2 ZHAO Ping2
1.Department of Gynecology & Obstetrics, Chongqing Public Health & Medical Center, Chongqing 400000, P.R.China;2. Chengdu Public Health & Medical Center,Chengdu Sichuan 610066,P.R.China
关键词:
艾滋病母婴传播三联抗病毒治疗妊娠病毒载量
Keywords:
HIV mother-to-fetus transmission three-combined antivirus therapy pregnancy viral load
分类号:
R 714.251
摘要:
目的观察齐多夫定(zidovudine,AZT)+拉米夫定(lamivudine,3 TC)+克力芝(lopinavir and ritonavir tablets,LPV/r)三联抗病毒方案用于预防艾滋病母婴传播的临床效果。 方法收集2013~2015年在成都市公共卫生临床医疗中心接受AZT+3 TC+LPV/r方案进行艾滋病母婴阻断的人类免疫缺陷病毒(human immunodeficiency virus,HIV)阳性孕产妇病历记录,对其用药情况、病毒载量监测和CD 4+T淋巴细胞计数结果与其他妊娠结局指标进行描述性统计分析。 结果318例患者中分娩194例(610 %),其中剖宫产152例(784 %);平均产前用药时间(245±62)周,中途中断服药比例为366 %(71/194);产前病毒载量(012±004)lg copies/mL,比服药前(398±065)lg copies/mL显著下降(P<005);CD 4+T淋巴细胞计数用药后(50413±18746)/mm3较用药前(38459±19265)/mm3显著升高(P<005);新生儿追踪至18月龄经HIV抗体检测确诊发生感染3例(152 %)。 结论艾滋病母婴阻断有赖于早期系统化的综合干预措施,通过现有艾滋病母婴阻断项目的支持,及时对筛查阳性孕妇实施三联抗病毒治疗,能够有效预防母婴传播和减少艾滋病母婴危害。
Abstract:
ObjectiveTo analyze the clinical effects of three-combined high efficient antiretroviral therapy (HAART) for preventing mother-to-fetus transmission of HIV. MethodsWith the 3-combined HAART of AZT+3TC+LPV/r adopting to prevent transmission of HIV infected women during 2013~2015 in Chengdu Public Health & Medical Center, we made a retrospective study to compare the basic pregnancy outcome indicators, and the plasma HIV load and the number of CD4+ T lymphocytes were detected and compared at treatment beginning with a week ahead laboring. ResultsAmong the 318 patients, the ratio of pregnancy to delivery was 610 % (194/318), and the rate of caesarean section was 784 % (152/194). The average prenatal drug use time was (245 ± 62) weeks, and the proportion of patients who interrupted the treatment was 366 % (71/194);the viral load before laboring was (012±004)lg copies/mL, which obviously lower than that before using anti-virus drugs (398±065)lg copies/mL(P<005), and the CD4+ T-lymphocyte count was significantly higher than before treatment (P<005). The HIV virus infection rate of new-born was 152 % (3/197) with the tracing duration till 18 months after laboring. ConclusionIt is depended the early continued comprehensive intervention of anti-virus in blocking mother-to-fetus transmission of HIV ,and the 3-combined HAART of AZT+3 TC+LPV/r was efficiency to be used with the women who were found HIV positive during screening of pregnancy.

参考文献/References:

[1]王临虹.妇女艾滋病及母婴传播预防服务指南 [M].北京:人民卫生出版社,2011:P26-P39. [2]李燕.艾滋病母婴传播预防进展 [J].昆明医科大学学报,2012,33(11):1-3. [3]胡海梅.两种高效抗反转录病毒方案预防艾滋病母婴传播的效果 [J].中国妇幼保健,2012,27(7):2627-2631. [4]高丽萍,杨一青,董有芹,等.不同抗逆转录病毒药物方案预防艾滋病母婴传播的效果分析 [J].中国妇幼卫生杂志,2015,6(6):65-66. [5]黄春明,林桂芳.2011-2013年广西北海市艾滋病母婴传播阻断现状及效果分析 [J].中国妇幼保健,2015,30(21):3580-3582. [6]Currie S, Rogstad KE, Piyadigamage A, et al Time taken to undetectable viral load, following the initiation of HAART [J]. Int J STD AIDS, 2009, 20 (4): 265-266. [7]王爱玲,王潇滟,窦丽霞,等.中国HIV感染孕产妇早产及其影响因素分析 [J].中华流行病学杂志,2015,36(4):349-353. [8]ZHOU Zengquan, Meyers K, LI Xia, et al. Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China [J]. J Acquir Immune Defic Syndr, 2010, 53 (Suppl 1): S 15-S 22. [9]Cohen MS, Chen YQ, Mccauley M, et al. Prevention of HIV-1 infection with early antiretroviral therapy [J]. N Engl J Med, 2011, 365 (6): 493-505. [10]卫生部.预防艾滋病,梅毒,乙肝母婴传播工作实施方案 [Z],2015.

相似文献/References:

[1]武俊青,李玉艳,罗迈,等.计划生育和卫生部门联合开展艾滋病自愿咨询检测和自愿咨询转诊的定性研究[J].中国计划生育和妇产科,2011,(01):0.
 WU Jun-qing,LI Yu-yan,LUO Mai,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2011,(12):0.
[2]陶涛,钟兴明,高建群,等.广州市乙型肝炎病毒母婴传播阻断实施3年分析[J].中国计划生育和妇产科,2013,(03):0.
 TAO Tao,ZHONG Xing - ming *,GAO Jian - qun,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2013,(12):0.
[3]刘敬涛,蒲杰,许跃忠,等.四川省艾滋病高发区艾滋病病毒感染孕产妇卫生保健服务利用现状分析[J].中国计划生育和妇产科,2016,(02):0.
 LIU Jing-tao,PU Jie,XU Yue-zhong,et al.[J].Chinese Journal of Family Planning & Gynecotokology,2016,(12):0.
[4]龚毅.彝族人群艾滋病知识行为状况分析[J].中国计划生育和妇产科,2016,(02):0.
 GONG Yi,[J].Chinese Journal of Family Planning & Gynecotokology,2016,(12):0.
[5]刘敬涛,蒲杰*,许跃忠,等.凉山州孕产妇围产保健服务利用现状分析[J].中国计划生育和妇产科,2017,(8):68.
 LIU Jing-tao,PU Jie*,XU Yue-zhong,et al.Analysis on the utilization of perinatal health care services of pregnant women in Liangshan area[J].Chinese Journal of Family Planning & Gynecotokology,2017,(12):68.
[6]蒲杰,孙玲玲 综述,刘兴会* 审校.产前预防乙型肝炎病毒母婴传播现状与进展[J].中国计划生育和妇产科,2019,(9):10.
[7]张飘,何丹,刘伟信*.有效预防艾滋病母婴传播,助力全面小康建设 ——以四川省预防艾滋病母婴传播工作实践为例[J].中国计划生育和妇产科,2020,(8):3.
[8]蒋琪,熊复,彭晓,等.早产儿乙肝病毒母婴阻断的相关研究进展[J].中国计划生育和妇产科,2020,(8):8.

备注/Memo

备注/Memo:
四川省卫生计生科研基金项目(项目编号: 16PJ082)
更新日期/Last Update: 2018-12-25